STAMP+CBT mHealth for Cancer Pain (NCT05403801) | Clinical Trial Compass
CompletedNot Applicable
STAMP+CBT mHealth for Cancer Pain
United States10 participantsStarted 2022-07-01
Plain-language summary
The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- PILOT COHORT
* Age ≥ 18 years
* Patients diagnosed with an active cancer diagnosis, either undergoing active cancer treatment or receiving treatment for an advanced cancer or are receiving palliative care
* Treatment managed at participating clinic (DFCI outpatient palliative care, gastrointestinal cancer center, and DFCI satellite clinic Merrimack Valley or Londonderry)
* Chronic pain related to cancer or treatment (\> pain score of 4)
* Has an active prescription for at least one opioid medication to treat their cancer pain (i.e. not for post-surgical pain)
* Own a compatible smartphone (android) or is willing to use an android device provided by the study team
* Completes baseline survey
Exclusion Criteria:
* Patients in survivorship: patients who have completed their treatment regimens, are not actively receiving treatment for an advanced cancer, or have a cancer that is in remission
* Cognitive impairment that would interfere with study participation, as judged by treating clinician
* Inability to speak English: the intervention has not yet been translated to Spanish
* History of opioid use disorders
* Enrolled in hospice
* Currently hospitalized
* Use of transmucosal fentanyl, given safety concerns and ongoing risk mitigation program required to prescribe these (TIRF REMS).
* Pain primarily related to a recent surgery